InvestorsHub Logo
Followers 971
Posts 383012
Boards Moderated 6
Alias Born 06/24/2011

Re: None

Thursday, 06/14/2018 1:29:46 PM

Thursday, June 14, 2018 1:29:46 PM

Post# of 6013
Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator specializing in hemp based health and wellness products, the development of pharmaceutical CBD delivery methods and the manufacturing of a pure, natural CBD as an Active Pharmaceutical Ingredient (API) for use in finished pharmaceutical products (FPPs), announces unaudited May 2018 consolidated revenue numbers of $3,316,646 CDN. https://finance.yahoo.com/news/isodiol-international-inc-announces-may-090000060.html